Aurobindo Pharma Reports 2% Rise in Q4 Net Profit on Revenue Growth
11 minutes agoBusiness
30LENS
3 SourcesNew Delhi, India
TBNthebalanced.news

Aurobindo Pharma Reports 2% Rise in Q4 Net Profit on Revenue Growth

Aurobindo Pharma reported a 2% increase in consolidated net profit to approximately Rs 921 crore for the fourth quarter ended March 31, compared to Rs 903 crore a year earlier. Revenue from operations rose 5.6% to about Rs 8,853 crore, supported by growth in Europe and other markets despite a 13% decline in U.S. formulations revenue. For the fiscal year 2026, net profit remained nearly flat at around Rs 3,503 crore, with a 6.1% increase in revenue to Rs 33,653 crore. The company highlighted strong performance driven by operational efficiencies and an extensive product portfolio.

Political Bias
0%100%0%
Sentiment
65%
AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 21 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 3 sources
● Left 0%● Center 100%● Right 0%

The articles present a straightforward business update focusing on financial performance without political framing. Both sources emphasize the company's profit and revenue figures, operational strengths, and market performance. There is no evident political perspective or partisan interpretation, reflecting neutral corporate reporting.

Sentiment — Neutral (65/100)

The overall tone across the articles is positive, highlighting modest profit growth and revenue increases. While noting a decline in U.S. formulations revenue, the coverage emphasizes resilience and operational efficiency. The sentiment is balanced, focusing on factual financial results without exaggeration or criticism.

How 3 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
moneycontrolAurobindo Pharma Q4 profit inches up 2 as Europe, growth markets offset US drag- Moneycontrol.comCenterNeutral
thehinduAurobindo Pharma Q4 net up 2 to 921 crCenterPositive
news18Aurobindo Pharma Q4 PAT edges up 2 pc at Rs 920.84 crCenterNeutral

Coverage timeline

news18 broke this story on 21 May, 03:53 pm. Other outlets followed.

  1. 1
    news1821 May, 03:53 pm
    Aurobindo Pharma Q4 PAT edges up 2 pc at Rs 920.84 cr
  2. 2
    thehindu21 May, 05:04 pm
    Aurobindo Pharma Q4 net up 2 to 921 cr
  3. 3
    moneycontrol21 May, 05:15 pm
    Aurobindo Pharma Q4 profit inches up 2 as Europe, growth markets offset US drag- Moneycontrol.com

Lens Score breakdown

30/100
Public interest0/100
Coverage gap100%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Aurobindo Pharma LtdAurobindo Pharma

Story context

Category
Business
Location
New Delhi, India
Sources analysed
3
Last analysed
21 May 2026
Key entities
CroreIndian rupeeEuropeNet incomeChief executive officerEuroRevenueBusiness modelNew DelhiRegional Basketball League (Lithuania)Basketball Africa LeaguePress Trust of India